TISSUE REGENIX
Tissue Regenix commercializes innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. Tissue Regenix was founded in May 2006, to commercialize innovative technologies in regenerative medicine.
TISSUE REGENIX
Industry:
Health Care Health Diagnostics Medical Device
Founded:
2006-05-01
Address:
York, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.tissueregenix.com
Total Employee:
51+
Status:
Active
Contact:
+44 1904 567609
Email Addresses:
[email protected]
Total Funding:
15.29 M GBP
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving Apache Microsoft Exchange Online
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-07-21 | CellRight Technologies | CellRight Technologies acquired by Tissue Regenix | 30 M USD |
Investors List
Aquarius Equity Partners
Aquarius Equity Partners investment in Venture Round - Tissue Regenix
White Rose Technology Seedcorn Fund
White Rose Technology Seedcorn Fund investment in Venture Round - Tissue Regenix
IP Group
IP Group investment in Venture Round - Tissue Regenix
Official Site Inspections
http://www.tissueregenix.com
Unable to get host informations!!!
More informations about "Tissue Regenix" on Search Engine
Our story - Tissue Regenix
Spun out of the University of Leeds in 2006, Tissue Regenix commercialise research undertaken by our higher education and research partners around the world.See details»
Business overview - Tissue Regenix
TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilizing our two platform …See details»
Tissue Regenix - Crunchbase Company Profile & Funding
Organization. Tissue Regenix. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. About. Tissue Regenix commercializes innovative …See details»
Board of Directors - Tissue Regenix
Matrix OI ® FlexIt; Matrix OI ® 100 DBM Cortical fibres and fillers; Matrix OI ® Strips and BlocksSee details»
Business model - Tissue Regenix
About us. Business overview. Our locations. Our story. Regenerative medicine. Business model. Our technology. Our strategy. Sustainability. Board of Directors. Our team. …See details»
Tissue Regenix Group | LinkedIn
51-200 employees. Headquarters. Leeds, West Yorkshire. Type. Public Company. Founded. 2006. Specialties. Development, manufacture & commercialisation of medical …See details»
Sustainability - Tissue Regenix
Tissue Regenix’s vision to become a leader in regenerative medicine is underpinned by its core values to maintain a sustainable, ethical and responsible Company. Fundamental …See details»
Regenerative medicine - Tissue Regenix
Regenerative medicine is an interdisciplinary field which focuses on providing safe and reliable ways to repair, restore, or replace damaged tissues or organs. The two main …See details»
Tissue Regenix Group "has the opportunity to become a global …
Feb 2, 2023 Tissue Regenix Group PLC (AIM:TRX, OTC:TSSNF) chief executive Danny Lee and chief financial officer David Cocke speak to Proactive's Thomas Warner after …See details»
Our locations - Tissue Regenix
About us. Business overview. Our locations. Our story. Regenerative medicine. Business model. Our technology. Our strategy. Sustainability. Board of Directors. Our team. …See details»
Tissue Regenix - Contacts, Employees, Board Members, …
Organization. Tissue Regenix. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 6. Number of Board …See details»
Our technology - Tissue Regenix
DCELL ® Technology - Gentle soft tissue decellularization process, removing DNA and cellular material to reduce risk of rejection. Differentiated characteristics Maintaining the …See details»
Tissue Regenix Ltd To Present At Jefferies Healthcare ... - BioSpace
Jun 7, 2016 LEEDS, England--(BUSINESS WIRE)--Tissue Regenix Group (AIM:TRX) (“Tissue Regenix” or “The Group”) the regenerative medical devices company …See details»
Tissue Regenix Group on LinkedIn: Case study from Dr. Lambert
Tissue Regenix will announce its final results for the year ended 31 December 2023 on Tuesday 19 March 2024. Investor Briefing Daniel Lee, Chief Executive Officer, and …See details»
Tissue Regenix Group - New collaboration with leading …
Leeds, 11 May 2020- Tissue Regenix Group, a leading regenerative medicine company, is pleased to announce that it has entered a new strategic collaboration for white label …See details»
Tissue Regenix Group hiring PROJECT MANAGER in Universal …
Effectively interact with individuals at all levels of the organization and externally to successfully resolve people/business issues. ... Tissue Regenix/CellRight Technologies …See details»
Home - Tissue Regenix
Tissue Regenix Group is a pioneering, international medical technology company, focusing on the development of regenerative products. Our vision. Our vision is to establish …See details»
Global Tissue Engineering Market Analysis & Forecast to 2024-2034
Tissue Regenix Group plc 17.5. Organogenesis Holdings Inc. 17.6. Baxter International, Inc. 17.7. ACell, Inc. 17.8. Stryker Corporation 17.9. Athersys, Inc. 17.10. B. Braun ...See details»
Active Wound Care Market 2023 Major Key Players and Industry …
The major players in the Active Wound Care market include 3M Company, Smith & Nephew, Mölnlycke Health Care, Johnson & Johnson Services, Convatec Group plc, …See details»
TrueCardium® Cardiac Organoids | Exclusively by InSphero
Contact Us. Phone : +1 908-864-1550. TechPlace, 74 Orion St., Brunswick, ME 04011 USA. Phone : +41 44 515 04 90. Wagistrasse 27A, 8952, Schlieren, Switzerland. Harness the …See details»